Dual elimination of HIV/syphilis initiatives globally and an update on the status of dual HIV/syphilis RDT Research

//Dual elimination of HIV/syphilis initiatives globally and an update on the status of dual HIV/syphilis RDT Research

Dual elimination of HIV/syphilis initiatives globally and an update on the status of dual HIV/syphilis RDT Research

March 26th  9-10 hours

Zambezi Conference Room, CIDRZ Head Office 5032 Great North Road, Lusaka

Maura Laverty

Research Nurse Clinician, WHO Department of Reproductive Health

Maura Laverty has been a registered nurse for over 40 years, and has been heavily involved in the earliest research efforts to combat HIV/AIDS. After graduating from the Kings County Hospital School of Nursing in Brooklyn, NYC, USA in 1975, Mrs Laverty worked in emergency departments in New York City for a decade, during which time she witnessed the beginning of the AIDS epidemic in the US. In 1986, she was one of the first nurses to join the New York University School of Medicine clinical research team that conducted early HIV/AIDS research on AZT and every drug that came after, as well as several therapeutic and preventative HIV vaccines under Dr Fred Valentine. From 2002-2012, Mrs Laverty worked through a PEPFAR grant awarded to NYU School of Medicine to assist colleagues in Mombasa, Kenya to establish HIV care and treatment centers, eventually scaling up to treating over 20,000 adults and children with HIV. For the last year, Mrs Laverty has been working for the WHO under the direction of Dr Lori Newman studying strategies around the elimination of congenital syphilis and use of dual HIV/syphilis point of care rapid diagnostic tests.

By | 2015-03-23T08:19:28+00:00 March 23rd, 2015|Research Rounds|0 Comments

About the Author:

Leave A Comment